WallStreetZenWallStreetZen

NASDAQ: LABP
Landos Biopharma Inc Stock Ownership - Who owns Landos Biopharma?

Insider buying vs selling

Have Landos Biopharma Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when LABP insiders and whales buy or sell their stock.

LABP Shareholders

What type of owners hold Landos Biopharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Konstantin Poukalov477.10%14,869,915$320.60MInsider
Rtw Investments LP264.75%8,251,444$177.90MInsider
Josep Bassaganyariera183.55%5,720,868$123.34MInsider
Perceptive Advisors LLC99.17%3,090,924$66.64MInsider
Perceptive Advisors LLC47.71%1,486,991$32.06MInstitution
Jyoti Chauhan6.72%209,299$4.51MInsider
Macquarie Group Ltd0.47%14,718$317.32kInstitution
Geode Capital Management LLC0.40%12,604$271.74kInstitution
Renaissance Technologies LLC0.36%11,260$242.77kInstitution
Acadian Asset Management LLC0.00%134$2.89kInstitution

1 of 2

LABP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LABP4.53%95.47%
GNTA2.53%0.00%
YS10.08%0.00%
IKNA66.60%18.22%
THTX33.01%0.00%

Landos Biopharma Stock Ownership FAQ

Who owns Landos Biopharma?

Landos Biopharma (NASDAQ: LABP) is owned by 48.96% institutional shareholders, 1,031.29% Landos Biopharma insiders, and 0.00% retail investors. Konstantin Poukalov is the largest individual Landos Biopharma shareholder, owning 14.87M shares representing 477.10% of the company. Konstantin Poukalov's Landos Biopharma shares are currently valued at $317.62M.

If you're new to stock investing, here's how to buy Landos Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.